62 related articles for article (PubMed ID: 3377515)
1. Validity of the 'bioassay' for thioredoxin-reductase activity.
Fuchs J
Arch Dermatol; 1988 Jun; 124(6):849-51. PubMed ID: 3377515
[No Abstract] [Full Text] [Related]
2. Anthralin inhibits elevated levels of thioredoxin reductase in psoriasis. A new mode of action for this drug.
Schallreuter KU; Pittelkow MR
Arch Dermatol; 1987 Nov; 123(11):1494-8. PubMed ID: 2445297
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of 5,5'-dithiobis(2-nitrobenzamides) as alternative substrates for trypanothione reductase and thioredoxin reductase: a microtiter colorimetric assay for inhibitor screening.
Davioud-Charvet E; Becker K; Landry V; Gromer S; Logé C; Sergheraert C
Anal Biochem; 1999 Mar; 268(1):1-8. PubMed ID: 10036154
[TBL] [Abstract][Full Text] [Related]
4. The stereospecific suicide inhibition of human melanoma thioredoxin reductase by 13-cis-retinoic acid.
Schallreuter KU; Wood JM
Biochem Biophys Res Commun; 1989 Apr; 160(2):573-9. PubMed ID: 2719682
[TBL] [Abstract][Full Text] [Related]
5. The mechanism of action of the nitrosourea anti-tumor drugs on thioredoxin reductase, glutathione reductase and ribonucleotide reductase.
Schallreuter KU; Gleason FK; Wood JM
Biochim Biophys Acta; 1990 Aug; 1054(1):14-20. PubMed ID: 2200526
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical localization of thioredoxin and thioredoxin reductase in adult rats.
Rozell B; Hansson HA; Luthman M; Holmgren A
Eur J Cell Biol; 1985 Jul; 38(1):79-86. PubMed ID: 3896810
[TBL] [Abstract][Full Text] [Related]
7. Azelaic acid as a competitive inhibitor of thioredoxin reductase in human melanoma cells.
Schallreuter KU; Wood JM
Cancer Lett; 1987 Sep; 36(3):297-305. PubMed ID: 3652030
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological activity of prodrug inhibitors of the thioredoxin-thioredoxin reductase system.
Wipf P; Lynch SM; Powis G; Birmingham A; Englund EE
Org Biomol Chem; 2005 Nov; 3(21):3880-2. PubMed ID: 16240002
[TBL] [Abstract][Full Text] [Related]
9. Cell line-directed screening assay for inhibitors of thioredoxin reductase signaling as potential anti-cancer drugs.
Kunkel MW; Kirkpatrick DL; Johnson JI; Powis G
Anticancer Drug Des; 1997 Dec; 12(8):659-70. PubMed ID: 9448705
[TBL] [Abstract][Full Text] [Related]
10. Diaryl chalcogenides as selective inhibitors of thioredoxin reductase and potential antitumor agents.
Engman L; Cotgreave I; Angulo M; Taylor CW; Paine-Murrieta GD; Powis G
Anticancer Res; 1997; 17(6D):4599-605. PubMed ID: 9494575
[TBL] [Abstract][Full Text] [Related]
11. A 35 kDa NAD(P)H oxidase previously isolated from the archaeon Sulfolobus solfataricus is instead a thioredoxin reductase.
Ruocco MR; Ruggiero A; Masullo L; Arcari P; Masullo M
Biochimie; 2004 Dec; 86(12):883-92. PubMed ID: 15667938
[TBL] [Abstract][Full Text] [Related]
12. Thioredoxin reductase activity is decreased by selenium deficiency.
Hill KE; McCollum GW; Boeglin ME; Burk RF
Biochem Biophys Res Commun; 1997 May; 234(2):293-5. PubMed ID: 9177261
[TBL] [Abstract][Full Text] [Related]
13. Cyclodextrin-derived diorganyl tellurides as glutathione peroxidase mimics and inhibitors of thioredoxin reductase and cancer cell growth.
McNaughton M; Engman L; Birmingham A; Powis G; Cotgreave IA
J Med Chem; 2004 Jan; 47(1):233-9. PubMed ID: 14695837
[TBL] [Abstract][Full Text] [Related]
14. Glutathione reductase and thioredoxin reductase at the crossroad: the structure of Schistosoma mansoni thioredoxin glutathione reductase.
Angelucci F; Miele AE; Boumis G; Dimastrogiovanni D; Brunori M; Bellelli A
Proteins; 2008 Aug; 72(3):936-45. PubMed ID: 18300227
[TBL] [Abstract][Full Text] [Related]
15. Ebselen: a thioredoxin reductase-dependent catalyst for alpha-tocopherol quinone reduction.
Fang J; Zhong L; Zhao R; Holmgren A
Toxicol Appl Pharmacol; 2005 Sep; 207(2 Suppl):103-9. PubMed ID: 15979675
[TBL] [Abstract][Full Text] [Related]
16. Thioredoxin reductase in control of the pigmentary system.
Schallreuter KU; Wood JM
Clin Dermatol; 1989; 7(2):92-105. PubMed ID: 2667744
[No Abstract] [Full Text] [Related]
17. The NADPH thioredoxin reductase C functions as an electron donor to 2-Cys peroxiredoxin in a thermophilic cyanobacterium Thermosynechococcus elongatus BP-1.
Sueoka K; Yamazaki T; Hiyama T; Nakamoto H
Biochem Biophys Res Commun; 2009 Mar; 380(3):520-4. PubMed ID: 19250645
[TBL] [Abstract][Full Text] [Related]
18. Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase.
Gandin V; Fernandes AP; Rigobello MP; Dani B; Sorrentino F; Tisato F; Björnstedt M; Bindoli A; Sturaro A; Rella R; Marzano C
Biochem Pharmacol; 2010 Jan; 79(2):90-101. PubMed ID: 19665452
[TBL] [Abstract][Full Text] [Related]
19. Function of thioredoxin reductase as a peroxynitrite reductase using selenocystine or ebselen.
Arteel GE; Briviba K; Sies H
Chem Res Toxicol; 1999 Mar; 12(3):264-9. PubMed ID: 10077489
[TBL] [Abstract][Full Text] [Related]
20. Thioredoxin reductase inactivation as a pivotal mechanism of ifosfamide in cancer therapy.
Wang X; Zhang J; Xu T
Eur J Pharmacol; 2008 Jan; 579(1-3):66-73. PubMed ID: 18028906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
